bibliographic entry 1648696 [be/1648696]
https://w3id.org/oc/corpus/be/1648696

is a

• bibliographic reference

content

• Long, G. V, Stroyakovskiy, D, Gogas, H, Levchenko, E, de Braud, F, Larkin, J. (2015). Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet 386, 444–451. DOI: 10.1016/S0140-6736(15)60898-4 PMID: 26037941

references

• https://w3id.org/oc/corpus/br/1283708